Under the gun, Nymox sparks another rally with a new batch of follow-up BPH data
More than a year ago, Nymox Pharmaceutical managed to whip up a big rally for its battered stock $NYMX after claiming an unexpected turnaround for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
